RU EN

Tel.: +7 495 150 0680

Mon.-Fri.: 1000-1900

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Clear

News

«A.Zalesov & Partners» have procured a seven-fold reduction of the damages awarded from the client in a dispute on the infringement of two patents for the medication for cancer treatment

A foreign company filed an action against the client of «A.Zalesov & Partners» Patent & Law Firm - Pharmasyntez Group of Companies, one of the top leading biopharmaceutical companies - for the infringement of two Russian patents claiming the recovery of damages and the prohibition of the sale of a generic (a medication for the treatment of cancer) until 2026.

15.11.2024
Aleksey Zalesov Irina Ozolina Darya Kushnarenko Litigation Life Science
Aleksey Zalesov made a report at a round table on the topic of pharmaceutical products circulation

On February 26, 2024, a panel discussion on the topic «On updating the introduction of the patent to an invention, utility model or industrial design when putting domestic medicines into the stream of commerce» took place in the State Duma.

01.03.2024
Aleksey Zalesov Life Science Conference
The Presidium of the Russian IP Court involved Dr. Aleksey Zalesov as a legal expert in a case regarding determining compliance with the «inventive step» patentability term of a new crystalline form of a substance

In the ruling issued, the Court agreed with the expert’s conclusion.

01.02.2024
Aleksey Zalesov Litigation Life Science
«A.Zalesov & Partners» have successfully represented the client in a long-running dispute on the legality of issuing a patent for an antidiabetic medication

The cassation instance ruled in favor of «A.Zalesov & Partners» having cancelled a judicial act contrary to the interests of the client and having forwarded an invalidation action against grant of a patent for reconsideration.

01.11.2023
Aleksey Zalesov Irina Ozolina Maria Makhlina Darya Kushnarenko Litigation Life Science
A complex and long-lasting dispute on the legality of granting a patent for an antidiabetic medication has completed in favor of «A.Zalesov & Partners» client

On October 02, 2023, the Presidium of the Russian IP Court adopted a very important resolution that changes the long-standing, however, erroneous approach of Rospatent to the rules for filing divisional applications.

16.10.2023
Aleksey Zalesov Irina Ozolina Maria Makhlina Darya Kushnarenko Litigation Life Science
A.Zalesov & Partners wins in the dispute on challenging the decision of the Ministry of Health of the Russian Federation to register the client’s medicinal product

By the resolution of the Moscow District Arbitration Court dated September 19, 2023, regarding case No. A40-202954/2022, the requirements of the cassation appeal filed in defense of the interests of a Russian pharmaceutical company - the client of «A.Zalesov & Partners» Patent & Law Firm - were satisfied.

02.10.2023
Aleksey Zalesov Julia Kolomytseva Litigation Life Science
«A.Zalesov & Partners» attained a reconsideration of the patent infringement dispute

On May 11, 2023, the Russian IP Court considered the cassation complaints of OOO «ALVILS» and AO «Kirov Pharmaceutical Factory» against the decision of the Moscow Arbitration Court dated August 26, 2022, regarding case No. A40-20467/2022 and the decision of the Ninth Arbitration Court of Appeal dated November 22, 2022, in the same case.

15.05.2023
Aleksey Zalesov Litigation Life Science
«A.Zalesov & Partners» will hold an affiliate session at the Distant & Digital conference

On February 08, 2022, the affiliate session of «A.Zalesov & Partners» - «Patent disputes in pharma: a letter of the law vs extreme necessity» - will take place within the framework of the Distant & Digital conference.

15.12.2021
Life Science Conference
«A.Zalesov & Partners» have protected the client’s interests in a patent dispute regarding the composition of insulin glargine at a concentration of 300 u/ml

On December 06, 2021, the Russian IP Court ruled in favor of the client of «A.Zalesov & Partners» Patent & Law Firm - «Geropharm» LLC, having  canceled the decision of Rospatent dated July 28, 2017, on the invalidation action regarding grant of RU patent No. 2564104 for the invention of «Long-acting Insulin Compositions» (patent owner - «SANOFI» Company) and sent the case to Rospatent for reconsideration.

15.12.2021
Patent Litigation Life Science
The Presidium of the Russian IP Court has ruled in favor of the client of «A.Zalesov & Partners»

On November 08, 2021, the Presidium of the Russian IP Court, as a court of cassation instance, upheld the ruling of the IP Court of July 21, 2021, which satisfied the claims of «Valenta Pharm» JSC - the client of «A.Zalesov & Partners» Patent & Law Firm - and terminated the legal protection of «Phenotropil» trademark and derivative designations.

15.11.2021
Trademark Litigation Life Science
«A.Zalesov & Patners» are the partners of the session at Distant & Digital Conference

On February 07-08, 2022, an international educational conference for experts in the field of transformation of law, intellectual property, creative industries, and the digital economy Distant & Digital will take place.

01.11.2021
Life Science Conference
«A.Zalesov & Partners» at the VIII Student Legal Forum

On October 21-23, 2021, the VIII Student Legal Forum took place at the Kutafin Moscow State Law University with the program, including 41 round tables and 20 masterclasses from practicing lawyers.

01.11.2021
Life Science Conference Julia Dutikova
Partners of «A.Zalesov & Partners» Patent & Law Firm Aleksey Zalesov and Irina Ozolina have successfully represented the client's interests before the Russian IP Court in a trademark non-use cancellation dispute

Our client, a Russian pharmaceutical manufacturer «VALENTAPHARM», had produced «Phenotropil» medication under a license agreement for more than 10 years.

30.07.2021
Trademark Non-use cancellation Life Science
The associates of «A.Zalesov & Partners» Patent & Law Firm have defended the interests of the client in the Chamber for Patent Disputes

Our client — «DIAMED-Pharma» LLC — filed an application to receive protection for a trademark under application № 2019746357 «PANTEIN» for goods in 03, 05, 10, 44 Classes of ICGS.

15.07.2021
Trademark Life Science
The Ninth Arbitration Court of Appeal ruled in favor of the client of «A.Zalesov & Partners» Patent & Law Firm in the unfair competition case

On June 15, 2021, the Court of Appeal upheld the decision of the Moscow Arbitration Court dated March 31, 2021, which in turn upheld the decision of the Federal Antimonopoly Service of the Moscow region to consider the illegal use of the patented invention of our client («DIAMED-Pharma» LLC) in the medication «Drastop» by «Trokas Pharma» LLC as an unfair competition act.

03.07.2021
Unfair competition Life Science
The Chamber for Patent Disputes ruled in favor of the client of «A.Zalesov & Partners» Patent & Law Firm

On June 9, 2021, the board of the Chamber for Patent Disputes satisfied an invalidation action against the Eurasian patent 017084 on the territory of Russia concerning a combined drug for the treatment of diabetes type II, including, in particular, a combination of vildagliptin and metformin.

16.06.2021
Patent Validity disputes Life Science
The Moscow Arbitration Court ruled in favor of the client of «A.Zalesov & Partners» Patent & Law Firm in an unfair competition case

We represented our client («DIAMED-Pharma» LLC) in an invalidation action filed by their competitor («Grotesk» LLC) against the decision of the Federal Antimonopoly Service of the Moscow Region

01.06.2021
Unfair competition Litigation Life Science
«A.Zalesov & Partners» Patent & Law Firm has successfully represented a client before the Arbitration Court of the Sverdlovsk region in a patent infringement dispute by amicable means

Our client «HAEMOGENICS» LLC has filed a lawsuit against «Alterus» LLC, a Russian distributor of medical equipment manufactured by Indian company «Mitra».

15.05.2021
Patent Litigation Life Science
An important decision of the Federal Antitrust Service in favor of the client of «A.Zalesov & Partners» Patent & Law Firm

Our client («TWINS TEC») filed an application with the Federal Antitrust Service claiming unfair competition caused by «MIRROLLA LAB» LLC that was imitating packages of our client and put the product into the stream of commerce.

15.04.2021
Trademark Unfair competition Life Science
The Presidium of the Russian IP Court upheld the previous decision made in favor of a client of «A.Zalesov & Partners» Patent & Law Firm LLC in a patent invalidation dispute regarding RU Design № 116098

Our client's («TWINS TEC») competitor brought a product to the market in a packaging similar to the packaging produced by our client.

02.04.2021
Design Litigation Life Science
«A.Zalesov & Partners» Patent & Law Firm contributes to fighting the pandemic

The COVID-19 pandemic caused a splash of patent activity in the pharmaceutical area in 2020. According to the data of Rospatent as of January 21, 2021, 570 applications for inventions were filed for termination of the coronavirus infection.

15.02.2021
Patent Life Science
«A.Zalesov & Partners» Patent & Law Firm has successfully defended the interests of its client «DIAMED-Pharma» LLC in the Chamber for Patent Disputes in patent dispute on validity of the client's patent № 2612014

On December 18, 2020, the Chamber for Patent Disputes issued a decision confirming the validity of the Russian patent № 2612014 for an invention related to an injectable form — a solution of chondroitin sulfate intended for the treatment of arthrological diseases.

30.12.2020
Patent Validity disputes Life Science
«A.Zalesov & Partners» Patent & Law Firm team has won two patent disputes simultaneously on unfair competition acts for its client and the patent holder for an arthrological drug

On December 17, 2020, the Federal Antimonopoly Service of the Moscow region held a hearing on two unfair competition disputes between «DIAMED-Pharma» LLC, the patent holder, «Trokas-Pharma» LLC (the first case) and «Groteks»  LLC (the second case). 

30.12.2020
Patent Unfair competition Litigation Life Science
The Russian IP Court has clarified that the Chamber for Patent Disputes is limited in sending the application for additional search when considering appeal against refusal in patent grant

On December 10, 2020, the Russian IP Court ruled in favor of «DIAMED-Pharma» LLC, client of «A.Zalesov & Partners» Patent & Law Firm. Regarding SIP-79/2020 case, and invalidated the decision of Rospatent rendered on the results of considering the refusal in grant of a Russian patent on application № 2015148217. 

15.12.2020
Patent Litigation Life Science
Is everything fair in antimonopoly and trademark wars? «A.Zalesov & Partners» Patent & Law Firm backed up the client's trademark registration which was challenged in order to avoid unfair competition claim

On October 30, 2020 the Russian IP Court ruled in favor of Rospatent's earlier decision where the Client's trademark registration was kept in force.

04.12.2020
Trademark Unfair competition Litigation Life Science
The IP Court ruled about legal consequences of wrong priority date of a Russian patent for composition of insulin glargine at a concentration of 300 u/ml

On September 17, 2020 the team of «A.Zalesov & Partners» Patent & Law Firm successfully proved before the Russian IP Court that the Russian patent № 2564104 «long-acting insulin compositions» (the patent holder is «Sanofi Aventis») does not meet the novelty and industrial applicability requirements.

20.10.2020
Patent Litigation Life Science
«A.Zalesov & Partners» Patent & Law Firm has successfully defended interests of «TEVA» in a patent infringement case initiated by «Gedeon Richter» over levonorgestrel comprising product «Model 911» based on its Eurasian patent EA 6545 in the Ivanovo Regio

January 18, 2020 the Ivanovo Regional Court's ruling entered into legal force confirming amicable settlement of the court case, where the Hungarian pharmaceutical company «Gedeon Richter» filed a patent infringement lawsuit against «Teva» LLC (Russian subsidiary of «TEVA Pharmaceutical industries» Ltd., Israel), a client of «A.Zalesov & Partners» Patent & Law Firm. 

03.02.2020
Patent Litigation Life Science
«A.Zalesov & Partners» Patent & Law Firm has successfully defended the interests of the client «ХANTIS PHARMA» (Slovenia) in a patent infringement lawsuit filed by «ASTELLAS PHARMA» (Japan) in the Moscow City Court

On January 10, 2020 the Moscow City Court approved an amicable settlement between «ХANTIS PHARMA» and «ASTELLAS PHARMA» in a patent infringement lawsuit filed by the latter based on the Russian invention patent 2143432, which is a term extended patent for a pharmaceutical composition.

03.02.2020
Patent Litigation Life Science
The IP Court ruled in favor of the client of «A.Zalesov & Partners» Patent & Law Firm - Russian pharmaceutical distribution company «R-Pharm» in invalidation trial over secondary pharmaceutical Russian patent RU 2567537 owned by «Nativa» Ltd. which was i

On December 26, 2019 the IP Court ruled in favor of the client of «A.Zalesov & Partners» Patent & Law Firm a Russian pharmaceutical distribution company «R-Pharm» in an invalidation trial over a secondary pharmaceutical Russian patent RU 2567537 belonging to «Nativa» Ltd.

08.01.2020
Patent Litigation Life Science
The Chamber for Patent Disputes of Rospatent satisfied an invalidation action against Russian patent RU 2564104 owned by «Sanofi» relating to a pharmaceutical composition of insulin glargin composition which includes 300 Unit/ml

On December 20, 2019 the Chamber for Patent Disputes of Rospatent satisfied an invalidation action against Russian patent RU 2564104 owned by «Sanofi» related to a pharmaceutical composition of insulin glargin composition which includes 300 Unit/ml for treatment of diabetes type I and type II. The disputes on validity of this patent have a long story.

08.01.2020
Patent Litigation Validity disputes Life Science
License fee USD 300 instead of reinstatement of damages more than USD 12,000,000: amicable settlement in favor of a client «A.Zalesov & Partners» Patent & Law Firm

On July 17, 2019 the Arbitration Court of Saint Petersburg confirmed amicable settlement in a patent infringement case №А56-116678/2017 started in 2017.

27.09.2019
Patent Litigation Life Science
«A.Zalesov & Partners» Patent & Law Firm team spoke at the conference «Modern Regulation of Intellectual Property and Licensing in the Eurasian Economical Union» in Minsk, Belarus

Irina Ozolina, Senior Partner, and Dr. Yulia Dutikova, Leading Patent Specialist of «A.Zalesov & Partners» Patent & Law Firm spoke at the conference «Modern Regulation of Intellectual Property and Licensing in the Eurasian Economic Union» held in Minks, Belarus on June 05-08, 2019.

11.06.2019
Irina Ozolina Life Science Conference Julia Dutikova
A Court of appeal put an injunction against a food supplement infringing a trademark of a Client of «A.Zalesov & Partners» Patent & Law Firm

A client of «A.Zalesov & Partners» Patent & Law Firm filed a lawsuit with the Moscow Region Arbitration Court requesting that the defendant is forced to stop selling the food supplement «ЦИМИЦИКЛИМ» (TSIMITSIKLIM) as infringing the trademark «ЦИ-КЛИМ» (TSI-KLIM) (RU510846) and to publish the court's decision.

24.04.2018
Trademark Litigation Life Science
Services
Team
Credentials and press
Publications
Blog
News
Contacts
© 2024 A.Zalesov & Partners Patent & Law Firm
made by AXIO web
RU EN